Literature DB >> 22311385

A clinical case study of a Wolfram syndrome-affected family: pattern-reversal visual evoked potentials and electroretinography analysis.

Ewa Langwińska-Wośko1, Karina Broniek-Kowalik, Kamil Szulborski.   

Abstract

Wolfram syndrome (WFS), or DIDMOAD, is a rare (1/100 000 to 1/770 000), progressive neurodegenerative disorder. In its early stages, it is characterized by insulin-dependent diabetes mellitus, optic atrophy and loss of sensorineural hearing-this is followed by diabetes insipidus, progressive neurological abnormalities and other endocrine abnormalities, which occur in later years. The aim of this study was to report on the clinical and electrophysiological findings from a family with the WFS1 mutation. The five family members were subjected to a complete ophthalmic examination, which included a flash full-field electroretinogram and pattern-reversal visual evoked potentials (PVEPs) performed according to ISCEV standards. Optic atrophy was confirmed in two homozygotic patients, where P100 latencies were significantly delayed-up to 146 ms in PVEP. P100 latencies were normal in the three heterozygotic patients we examined. Curve morphology abnormalities were observed in all five patients we examined. No literature describing the morphology of PVEP in Wolfram syndrome patients was found. In flash electroretinography, scotopic and photopic responses appeared in normal morphology and value. Diabetic retinopathy was not observed in the diabetes mellitus patients.

Entities:  

Mesh:

Year:  2012        PMID: 22311385     DOI: 10.1007/s10633-011-9308-8

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  16 in total

1.  Wolfram syndrome: evidence of a diffuse neurodegenerative disease by magnetic resonance imaging.

Authors:  T A Rando; J C Horton; R B Layzer
Journal:  Neurology       Date:  1992-06       Impact factor: 9.910

2.  Autosomal recessive Wolfram syndrome associated with an 8.5-kb mtDNA single deletion.

Authors:  A Barrientos; J Casademont; A Saiz; F Cardellach; V Volpini; A Solans; E Tolosa; A Urbano-Marquez; X Estivill; V Nunes
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

3.  A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome).

Authors:  H Inoue; Y Tanizawa; J Wasson; P Behn; K Kalidas; E Bernal-Mizrachi; M Mueckler; H Marshall; H Donis-Keller; P Crock; D Rogers; M Mikuni; H Kumashiro; K Higashi; G Sobue; Y Oka; M A Permutt
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

4.  Morbidity and mortality in the Wolfram syndrome.

Authors:  B T Kinsley; M Swift; R H Dumont; R G Swift
Journal:  Diabetes Care       Date:  1995-12       Impact factor: 19.112

5.  A rare coding variant within the wolframin gene in bipolar and unipolar affective disorder cases.

Authors:  R A Furlong; L W Ho; J S Rubinsztein; A Michael; C Walsh; E S Paykel; D C Rubinsztein
Journal:  Neurosci Lett       Date:  1999-12-24       Impact factor: 3.046

6.  Hearing impairment in genotyped Wolfram syndrome patients.

Authors:  Rutger F Plantinga; Ronald J E Pennings; Patrick L M Huygen; Rocco Bruno; Philipp Eller; Timothy G Barrett; Bernard Vialettes; Veronique Paquis-Fluklinger; Fortunato Lombardo; Cor W R J Cremers
Journal:  Ann Otol Rhinol Laryngol       Date:  2008-07       Impact factor: 1.547

7.  Incomplete Wolfram syndrome: clinical and electrophysiologic study of two familial cases.

Authors:  S Cillino; M Anastasi; G Lodato
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

8.  Wolfram syndrome: hereditary diabetes mellitus with brainstem and optic atrophy.

Authors:  N J Scolding; H F Kellar-Wood; C Shaw; J M Shneerson; N Antoun
Journal:  Ann Neurol       Date:  1996-03       Impact factor: 10.422

9.  Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein.

Authors:  T M Strom; K Hörtnagel; S Hofmann; F Gekeler; C Scharfe; W Rabl; K D Gerbitz; T Meitinger
Journal:  Hum Mol Genet       Date:  1998-12       Impact factor: 6.150

10.  Wolfram (DIDMOAD) syndrome: a multidisciplinary clinical study in nine Turkish patients and review of the literature.

Authors:  E Simsek; T Simsek; S Tekgül; S Hosal; V Seyrantepe; G Aktan
Journal:  Acta Paediatr       Date:  2003       Impact factor: 2.299

View more
  4 in total

1.  Ophthalmologic correlates of disease severity in children and adolescents with Wolfram syndrome.

Authors:  James Hoekel; Smith Ann Chisholm; Amal Al-Lozi; Tamara Hershey; Lawrence Tychsen
Journal:  J AAPOS       Date:  2014-10-21       Impact factor: 1.220

2.  Wolfram Syndrome: A case report of two sisters Wolfram Syndrome: Case report of two sisters.

Authors:  Tryfon Rotsos; Evangelia Papakonstantinou; Chrysanthos Symeonidis; Augoustinos Krassas; Smaragda Kamakari
Journal:  Am J Ophthalmol Case Rep       Date:  2022-03-01

3.  Impairment of visual function and retinal ER stress activation in Wfs1-deficient mice.

Authors:  Delphine Bonnet Wersinger; Nesrine Benkafadar; Jolanta Jagodzinska; Christian Hamel; Yukio Tanizawa; Guy Lenaers; Cécile Delettre
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

4.  A novel CISD2 intragenic deletion, optic neuropathy and platelet aggregation defect in Wolfram syndrome type 2.

Authors:  Enza Mozzillo; Maurizio Delvecchio; Massimo Carella; Elvira Grandone; Pietro Palumbo; Alessandro Salina; Concetta Aloi; Pietro Buono; Antonella Izzo; Giuseppe D'Annunzio; Gennaro Vecchione; Ada Orrico; Rita Genesio; Francesca Simonelli; Adriana Franzese
Journal:  BMC Med Genet       Date:  2014-07-24       Impact factor: 2.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.